Indeed, scRNA-seq data from 25 melanoma patients identifies a large population of CD8+ T cells showing continuous progression from early effector CD8+ T cells into dysfunctional CD8+ T cells, characterized by the progressive activation of immune checkpoint gene expression (53). The gene discussed is CD8A; the disease is melanoma.